Background: Mercaptopurine is a key agent in childhood leukemia treatment. Genetic polymorphism in the genes involving thiopurine metabolisms is related to 6-MP related toxicity.
Objective: This study aimed to determine the prevalence of and polymorphisms among Thai children diagnosed with leukemia and their association with mercaptopurine-related myelotoxicity.